New Study on Dual Use of Cigarettes and E-Cigarettes.

Nov.07.2022
New Study on Dual Use of Cigarettes and E-Cigarettes.
A new study published in the Addiction journal found that dual users of e-cigarettes and combustible cigarettes have lower levels of toxic chemicals.

A new study published in the scientific journal Addiction suggests that individuals who use nicotine vapor products or electronic cigarettes while trying to quit smoking have lower levels of toxic chemicals in their bodies. The study analyzed the biomarkers of nearly 1,300 individuals who either smoked traditional cigarettes, used e-cigarettes, or used both in what is known as dual use. The researchers found that compared to traditional cigarette smokers, those who used both products had lower levels of toxic chemicals such as carbon monoxide in their bodies. This contradicts previous beliefs that using e-cigarettes as a smoking cessation method would lead to increased smoking and greater exposure to harmful chemicals from both traditional and electronic cigarettes.


What is "dual use"? Dual use refers to continuing to smoke traditional cigarettes even after starting to use electronic cigarettes. This has become a common practice among those attempting to quit smoking using electronic cigarettes. Many opponents of electronic cigarettes point to the prevalence of dual use as evidence that electronic cigarettes do not help people quit smoking, but rather encourage the development of another harmful habit: vaping.


It cannot be denied that many people are smoking traditional cigarettes and using e-cigarettes simultaneously. Numerous studies in the past two years have repeatedly found that people attempting to quit smoking by using e-cigarettes continue to smoke traditional cigarettes. Additionally, researchers pointed out that the success rate of dual users quitting either traditional cigarettes or e-cigarettes is not higher than those who use nicotine replacement therapy.


Many studies over the past decade have consistently shown that electronic cigarette users frequently engage in dual use, meaning they continue to smoke traditional tobacco cigarettes while using e-cigarettes. This is the case in the United States, United Kingdom, and European Union. For example, American smokers report that e-cigarette use has remained unchanged for three consecutive years, dropping only slightly from 29.8% in 2015 to 27.7% in 2018.


A similar report exists in the United Kingdom as well. A study revealed that the rate of dual use of electronic and traditional cigarettes is higher among teenagers who only use e-cigarettes, despite them being the largest group in the survey. The research also showed that young people who started with traditional cigarettes are more likely to continue to smoke them even after starting to use e-cigarettes.


Many people from different countries and backgrounds, regardless of race and gender, engage in dual use behavior, which seemed to reinforce the belief that e-cigarettes are not helpful for quitting smoking. However, this new study overturns this assumption by stating that dual use is only a transition, not a permanent one.


Is Dual Use of Tobacco and E-cigarettes Risky? Many studies have hinted at the potential danger of using both tobacco and e-cigarettes simultaneously. For instance, one study suggests that the likelihood of developing cardiovascular diseases is higher in individuals who use both products compared to those who only use e-cigarettes but lower than those who only smoke tobacco. However, new evidence from a recent study reveals the opposite.


A new study has examined the levels of carbon monoxide in the breath of cigarette smokers, e-cigarette users and those who use both. The study found that the levels of carbon monoxide in the bodies of those who only use e-cigarettes were lower than those who smoke cigarettes or use both. However, compared to those who only smoke cigarettes, those who use both also had lower levels of carbon monoxide in their bodies.


Another study found that dual users were more likely to quit smoking after a period of time, rather than returning to using only one type or quitting altogether. However, the study also found that, aside from dual use, there were other factors that caused them to stop smoking, unrelated to whether they smoked cigarettes. This study also suggests that those who smoke cigarettes and use electronic cigarettes usually return to only smoking cigarettes.


Can e-cigarettes help you quit smoking? Despite new research, many public health organizations and policymakers are unlikely to change their views on e-cigarettes, at least in America. However, despite the risks, countries like the UK have already adopted e-cigarettes as another tool to help people quit more harmful smoking habits.


Although this new study does offer new evidence in support of the notion that dual smoking is not as harmful as smoking cigarettes alone, it is not definitive proof. Other factors aside from using electronic cigarettes or vaping are relevant in determining whether an individual can successfully quit smoking. However, this study does indicate that going through a transitional period during the process of quitting smoking is harmless.


Statement:


This article is compiled from third-party information and is intended for industry discussion and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The compilation of this article is intended only for industry exchange and research.


Due to limitations in our translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


Regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions, 2FIRSTS remains fully aligned with the Chinese government.


The compilation of information is the property of the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
The Philippines’ Bureau of Internal Revenue is intensifying enforcement against illicit vape and tobacco products ahead of the Christmas shopping season, directing regional and enforcement offices to strengthen monitoring of production sites, warehouses, distribution channels and retail outlets. The BIR destroyed 240,550 illicit vape products in August with an estimated tax liability of about PHP1.53 billion. A nationwide tax-compliance operation in July also inspected 3,590 businesses involved in tobacco and vapor products.
Regulations
Sep.17 by 2Firsts Perspectives
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09